Jubilant Life Sciences net profit falls 10 percent to Rs 224 crore in Q2 ruchika5 Nov 2020 5:51 AM GMTNew Delhi: Drug firm Jubilant Life Sciences on Wednesday reported a 10.13 percent decline in its consolidated net profit to Rs 224.12 crore for the qua...
Saptagir Labs, Jubilant Generics join hands to manufacture Remdesivir MD Bureau15 Sep 2020 7:30 AM GMTRemdesivir is an experimental antiviral drug developed by Gilead Sciences, Inc. as a course of treatment for COVID-19.
Saptagir Labs, Jubilant Generics join hands to manufacture Remdesivir MD Bureau14 Sep 2020 7:52 AM GMTRemdesivir is an experimental antiviral drug developed by Gilead Sciences, Inc. as a course of treatment for COVID-19.
Jubilant Life Sciences Q1 PAT down 52 pc at Rs 88 crore ruchika5 Sep 2020 3:45 AM GMTNoida: Jubilant Life Sciences on Friday reported a 52 percent fall in its profit after tax of Rs 88 crore in the April to June quarter as against Rs 18...
Covid Crisis: Jubilant Life Sciences to focus on operational, financial performance in near-term ruchika24 Aug 2020 7:11 AM GMTNew Delhi: Drug firm Jubilant Life Sciences is focused on sustaining its operational and financial performance in the near-term in the current scenario...
Jubilant Life Sciences launches remdesivir under brand name JUBI-R in India ruchika4 Aug 2020 7:30 AM GMTNoida: Jubilant Life Sciences Limited, an integrated global pharmaceutical and life sciences company, has announced that its subsidiary,...
Jubilant Life Sciences gets DCGI nod to JUBI-R for treating COVID-19 patients ruchika21 July 2020 11:46 AM GMTNoida: Jubilant Life Sciences Limited, an integrated global pharmaceutical and life sciences company, has announced that its subsidiary, Jubilant Gener...
Jubilant Life Sciences releases Q4 and FY20 Results ruchika30 May 2020 7:55 AM GMTNoida: The Board of Jubilant Life Sciences Limited, an integrated global pharmaceutical, and life sciences company met to approve financial results for...
Cipla board nod to Rs 3000 crore fundraising proposal Farhat Nasim18 May 2020 12:50 PM GMTNew Delhi: Amidst the economic impact of the COVID-19 pandemic, drug major Cipla Ltd recently apprised that the company's board had approved ...
Jubilant Life Sciences enters into Licensing Agreement with Gilead for Remdesivir, potential therapy for Covid-19 ruchika13 May 2020 3:45 AM GMTNoida: Jubilant Life Sciences Limited has announced that its subsidiary, Jubilant Generics Limited, has entered into a non-exclusive Licensing Agreemen...
